Data, Pharma & Fika

Welcome to the 7th episode of Data, Pharma, & Fika!The topic for this episode is inspired by Moneyball, the famous baseball story of how Billy Beane, the General Manager of the Oakland Athletics, used a sophisticated statistical approach called sabermetrics to analyze and obtain undervalued players.Our guest is Hiro Mori, former Head of Early asset Technology at UCB, the Belgian biopharmaceutical company, whose job is to evaluate technologies in order to optimize clinical performance.Listen to this exciting episode as our host Stephanie Mardini interviews Hiro about how UCB and Captario partnered up to quantify the effects of clinical trial technologies! Similar to the story of Moneyball, the goal was to use statistical modeling to analyze digital biomarkers and understand how a clinical trial with a limited budget can be successful.

For the 6th episode of Data, Pharma, & Fika, Captario has the pleasure of welcoming Eric Daimler, an authority in Artificial Intelligence & robotics, with over twenty years of experience in the field as an entrepreneur, investor, academic researcher, and policymaker.Join in together with our host Karl Rahn, and listen to Eric talk about how he defines AI, the importance of understanding AI governance, and how category theory within mathematics will transform the industry!During the Obama Administration, Daimler worked with the White House Office of Science and Technology as a Presidential Innovation Fellow. In that role, he helped to drive the agenda for U.S. leadership in research, commercialization, and public adoption of AI & Robotics. 

The celebration of Diversity continues in this part 2 of Diversity in STEM - Science, Technology, Engineering and Mathematics.There are many facets to diversity, looking at females in STEM, studies show that women are underrepresented in these fields, especially in technology, engineering, and senior leadership roles; UNESCO shows that the STEM workforce is 71% male and according to the Harvard Business Review, women in STEM are 45% more likely than men to leave the industry within one year.In this episode our amazing panel explains what commitment to diversity means, what shift we are seeing now and what the best thing with STEM is.Our panelists:·      Afshan Hussain – Senior Vice President, Client Services at Fishawack Health. She has over 20 years of experience in healthcare communication, she is an advocate for Diversity and Inclusion and has newly formed a nonprofit called the Rabab Foundation that focuses on health literacy and career mentorship.·      Lisa Pratt – A Physician and Pharmaceutical Executive with over 20 years’ experience, and most recently serving as Senior Vice President of Commercial Strategy at a biotech firm. She is also an advocate for women and girls who have suffered abuse.·      Sonali Bhavsar – Has over 20 years’ experience in data analytics, technology and management consultancy focusing on risk and compliance. Formerly a Managing director for the 4 big consulting firms and is a speaker and an advocate for diversity and inclusion.·      Michelle Scarbrough – Founder of Scarbrough Strategies and an Entrepreneur who helps business leaders leverage their data, analyze and optimize results. She has more than a decade of experience in data analytics and data science.Brought to you by: Captario, a Swedish tech company that helps pharma companies with analysis, forecasting and strategic decisions.Hosted by: Stephanie Mardini, an Analyst and a Customer Success Manager with a passion for thought leadership and creating a community of ideas, experiences and positivity.

In honor of April being Celebrate Diversity month, we want to dedicate this episode to celebrating Diversity in the STEM workforce which stands for Science, Technology, Engineering and Mathematics.There are many facets to diversity, looking at females in STEM, studies show that women are underrepresented in these fields, especially in technology, engineering, and senior leadership roles. We therefore have a panel of 4 amazing women with different backgrounds who share their stories, explain what STEM has to lose if the barriers aren’t broken down and to encourage people from different backgrounds and genders to go into STEM because it is only together that we can contribute to innovation and create a better future.Our panelists:Afshan Hussain - Senior Vice President, Client Services at Fishawack Health. She has over 20 years of experience in healthcare communication, she is an advocate for Diversity and Inclusion and has newly formed a nonprofit called the Rabab Foundation that focuses on health literacy and career mentorship.Lisa Pratt -  A Physician and Pharmaceutical Executive with over 20 years’ experience, and most recently serving as Senior Vice President of Commercial Strategy at a biotech firm. She is also an advocate for women and girls who have suffered abuse.Sonali Bhavsar - Has over 20 years’ experience in data analytics, technology and management consultancy focusing on risk and compliance. Formerly a Managing director for the 4 big consulting firms and is a speaker and an advocate for diversity and inclusion.Michelle Scarbrough - Founder of Scarbrough Strategies and an Entrepreneur who helps business leaders leverage their data, analyze and optimize results. She has more than a decade of experience in data analytics and data science.Brought to you by: Captario, a Swedish tech company that helps pharma companies with analysis, forecasting and strategic decisions.Hosted by: Stephanie Mardini, an Analyst and a Customer Success Manager with a passion for thought leadership and creating a community of ideas, experiences and encouragement.

Around 30 million people are diagnosed with Alzheimer´s disease. What if there could be a vaccine for Alzheimer´s? The episode guest is Ingela Nylander, Development Project Director at Alzinova - a swedish biopharma company pioneering the work for a vaccine for Alzheimer´s Disease. We also go all the way back to the start of a project and see what role data plays in those early stages.Contact UsPODCAST CREWPlease feel free to contact us with feedback or if you feel you can contribute to this PodCast in any way.podcast@captario.comEPISODE GUESTALZINOVAwww.alzinova.comIngela Nylanderingela.nylander@alzinova.com

Non-Adherence in clinical trials can cause a multitude of consequences - for the patient, for the pharmaceutical company and for society. Our guest Jesper Hassel explains many facets of this dilemma and give some insights on how adherence can be monitored.For further information on Mevias solution please contact:www.mevia.sejesper@mevia.seYou can also contact us on:podcast@captario.com

Mats Jirstrand from Fraunhofer-Chalmers Centre joins us in this digital meeting. Mr Jirstrand talks about the use of Machine Learning in various industries, how it has been used in the pandemic and what can be expected in the future.